openPR Logo
Press release

Key Trends Influencing the Growth of the Bioimpedance Analyzers Market in 2025: New Generation of Body Composition Scales Offers Superior Accuracy And Comprehensive Analysis

08-04-2025 12:33 PM CET | Health & Medicine

Press release from: The Business Research Company

Bioimpedance Analyzers

Bioimpedance Analyzers

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Bioimpedance Analyzers Market Through 2025?
The market for bioimpedance analyzers has seen swift expansion in recent times. The market worth is projected to increase from $0.59 billion in 2024 to $0.67 billion in 2025, boasting a compound annual growth rate (CAGR) of 14.5%. This growth during the historical period can be traced back to factors such as the escalating obesity crisis, shifting lifestyle habits, an upsurge in home delivery services, increasing cases of blood-related disorders like anemia and leukemia, the widespread occurrence of chronic illnesses, and a rising elderly demographic.

What's the Projected Size of the Global Bioimpedance Analyzers Market by 2029?
Projected to witness significant expansion in the upcoming years, the bioimpedance analyzers market is anticipated to reach a value of $1.14 billion by 2029, growing at a compound annual growth rate (CAGR) of 14.1%. The surge during the forecast period is largely due to advances in healthcare infrastructure, an increase in funding and initiatives, heightened health consciousness, escalated expenditure on healthcare services, and the rising intake of junk food. The forecast period will also see key trends such as the progress in technology, individualized healthcare solutions, the uptake of telehealth services, non-intrusive technologies, and the blending with wearable technology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/bioimpedance-analyzers-global-market-report

Top Growth Drivers in the Bioimpedance Analyzers Industry: What's Accelerating the Market?
Escalating worries surrounding obesity are anticipated to fuel the growth of the bioimpedance analyzers market in the coming years. Obesity, characterized by the significant accumulation of body fat, is a chronic health concern that poses a detrimental impact on well-being. The surge in obesity-related issues can be attributed to the easy accessibility of food with high sugar, calorie, and fat content, coupled with sedentary lifestyles and reduced levels of daily physical activity. Bioimpedance analyzers play a key role in the management of obesity, providing critical data on body structure that allows for tailored treatment procedures, health hazard monitoring, patient encouragement, fluid balance analysis, and improvements in clinical results and research initiatives. For example, the World Heart Foundation, a non-government cardiovascular community based in Switzerland, reported in March 2023 that around 2.3 billion adults and children worldwide are obese or overweight. Given the current trend, it's projected that this figure will rise to 2.7 billion by 2025. Consequently, heightened obesity concerns are steering the growth of the bioimpedance analyzers market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18256&type=smp

What Trends Will Shape the Bioimpedance Analyzers Market Through 2029 and Beyond?
Major firms in the bioimpedance analyzer market are focusing on the invention of pioneering products like the body composition scale. The goal is to deliver more precise and thorough health evaluations and make it more user-friendly. A body composition scale uses bioimpedance analysis (BIA) to determine an array of body components, delivering an analysis that goes beyond mere body weight, making them popular tools for personal health and fitness tracking. An illustration of this occurred in September 2022, when Xiaomi, a Chinese electronics firm, unveiled its eight-electrode body composition scale. This advanced scale uses dual-frequency bioimpedance measurement technology, giving it the edge to generate up to 35 body composition analysis reports with greater accuracy than older single-frequency scales. It utilizes multi-frequency biological alternating current, ensuring precise measurement of body aspects like fat, water, muscle, among others.

What Are the Main Segments in the Bioimpedance Analyzers Market?
The bioimpedance analyzers market covered in this report is segmented -

1) By Type: Multi Frequency, Single Frequency, Dual Frequency
2) By Modality: Wired Bioimpedance, Wireless Bioimpedance
3) By Application: Whole Body Measurement, Segmental Body Measurement
4) By End User: Hospitals, Fitness Clubs And Wellness Centers, Home Users, Other End-Users

Subsegments:
1) By Multi-Frequency: Bioimpedance Analyzers With Multiple Frequency Settings, Multi-Frequency Body Composition Analyzers
2) By Single-Frequency: Single-Frequency Bioimpedance Analyzers, Single-Frequency Body Composition Analyzers
3) By Dual-Frequency: Dual-Frequency Bioimpedance Analyzers, Dual-Frequency Body Composition Analyzers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18256&type=smp

Which Top Companies are Driving Growth in the Bioimpedance Analyzers Market?
Major companies operating in the bioimpedance analyzers market are Xiaomi Corporation, Omron Corporation, Beurer GmbH, InBody Co Ltd., Seca GmbH & Co., Withings, Lumsail Industrial Inc., Zurich Instruments Ltd., RJL Systems Inc., ImpediMed Limited, Biodynamics Corporation, Charder Electronic Co Ltd., Akern Srl, Bioparhom, BioTekna Limited, Bodystat Ltd., EVOLT 360 Limited, Maltron International Ltd., Tanita Corporation, Tongfang Health Technology (Beijing) Co.Ltd

Which Regions Will Dominate the Bioimpedance Analyzers Market Through 2029?
North America was the largest region in the bioimpedance analyzer market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioimpedance analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18256

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Key Trends Influencing the Growth of the Bioimpedance Analyzers Market in 2025: New Generation of Body Composition Scales Offers Superior Accuracy And Comprehensive Analysis here

News-ID: 4131458 • Views:

More Releases from The Business Research Company

Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Forecast Report
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025? The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of
Sustained Release Excipients Market Advances With Product Innovation Industry Trends Gaining Momentum in the Global Sustained Release Excipients Market
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therapeutics Market Driving Market Acceleration in the RNA Targeting Small Molecules Therapeutics Industry, 2025
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025? In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as a Core Driver of the Remicade Biosimilar Market in 2025
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025? In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic

All 5 Releases


More Releases for Bioimpedance

Bioimpedance Device Market: A Guide to Understanding the Process
The global Bioimpedance Device Market is estimated to be valued at USD 1.2 billion in 2024 and is anticipated to reach USD 2.8 billion by 2033, growing at a CAGR of 10.2% during the forecast period from 2025 to 2033. Bioimpedance Device Market Overview The Bioimpedance Device Market is witnessing steady growth driven by increasing applications in healthcare diagnostics, fitness monitoring, and body composition analysis. These devices measure electrical impedance to
Primary Catalyst Driving Bioimpedance Analyzers Market Evolution in 2025: Rising …
"What Is the Future Outlook for the Bioimpedance Analyzers Market's Size and Growth Rate? The market capacity of bioimpedance analyzers has expanded significantly over the past few years, with the projection to rise from $0.59 billion in 2024 to $0.67 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.5%. Factors contributing to the growth during the historical period include the escalating obesity crisis, evolving lifestyle trends, a surge
Bioimpedance Analyzers Market worth $927 million by 2028
Bioimpedance Analyzers Market in terms of revenue was estimated to be worth $564 million in 2023 and is poised to reach $927 million by 2028, growing at a CAGR of 10.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rising initiatives by government in promoting healthy lifestyle to curb obesity, growing number of gyms and wellness centers, strong
Bioimpedance Analyzers Market to reach USD 927 million by 2028
"The rise in obesity rate is expected to drive the demand of the market." The global bioimpedance analyzers market is projected to reach USD 927 million by 2028 from USD 564 million in 2023, at a CAGR of 10.4% during the forecast period. The growth of this market is majorly driven by the promotion of healthy lifestyles by the government, growing fitness and wellness centers, and an increase in the number
Bioimpedance Analyzers Market: Global Industry Analysis And Forecast 2023 - 2029
Market Overview: The Global Bioimpedance Analyzers market was valued at USD 465.58 million in 2021 and is expected to reach USD 836.45 million by the year 2028, at a CAGR of 8.73%. The screening instrument that can be used to measure and accurately analyze body composition and body fat is known as a bioimpedance analyzer (BIA). It is a non-invasive instrument that doctors use to calculate body fat percentage. Additionally, it enables
Single-frequency Bioimpedance Devicess Market: Competitive Dynamics & Global Out …
New report published by Market Research Report Store (MRRS) which offers insights on the global Single-frequency Bioimpedance Devicess market. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/242079/global-single-frequency-bioimpedance-devicess-market Global Single-frequency Bioimpedance Devicess Market: Forecast by Type / Application / Region According to this study, over the next five years the Single-frequency Bioimpedance Devicess market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million